T helper subsets in allergic eye disease

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 5, 2014, Pages 477-484

  Reyes, Nancy J ^a   Saban, Daniel R ^a,b  

^a Department of Ophthalmology ^*  (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

allergic conjunctivitis; allergy; keratoconjunctivitis; ocular allergy; T helper subsets

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 17;

CD4+ T LYMPHOCYTE; CONJUNCTIVA; DISEASE SEVERITY; EOSINOPHIL; EYE ALLERGY; HELPER CELL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INNATE IMMUNITY; KERATITIS; LYMPHOID CELL; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; DISEASE MODEL; EYE; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; PROCEDURES; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; DISEASE MODELS, ANIMAL; EYE; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INTERLEUKIN-17; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84906935006     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000088     Document Type: Review

References (119)

1. Bielory L. American Academy of Allergy, Asthma & Immunology - 2008 Annual Meeting. IDrugs 2008; 11:309-311.
2. Chigbu DI. The management of allergic eye diseases in primary eye care. Cont Lens Anterior Eye 2009; 32:260-272.
3. Bielory L. Allergic and immunologic disorders of the eye. Part II. Ocular allergy. J Allergy Clin Immunol 2000; 106:1019-1032.
4. Bilkhu PS, Wolffsohn JS, Naroo SA. A review of nonpharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis. Cont Lens Anterior Eye 2012; 35:9-16.
5. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115:118-122.
6. McKenzie GJ, Fallon PG, Emson CL, et al. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189:1565-1572.
7. Rankin JA, Picarella DE, Geba GP, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996; 93:7821-7825.
8. Munitz A, Brandt EB, Mingler M, et al. Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci USA 2008; 105:7240-7245.
9. Niederkorn JY. Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models. Curr Opin Allergy Clin Immunol 2008; 8:472-476.
10. Galatowicz G, Ajayi Y, Stern ME, et al. Ocular antiallergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin Exp Allergy 2007; 37:1648-1656.
11. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol 2011; 11:477-482.
12. Anderson DF, MacLeod JD, Baddeley SM, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration. Clin Exp Allergy 1997; 27:1060-1066.
13. Yao L, Baltatzis S, Zafirakis P, et al. Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Ocul Immunol Inflamm 2003; 11:211-222.
14. Irani AM, Butrus SI, Tabbara KF, et al. Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol 1990; 86:34-40.
15. Chen JJ, Applebaum DS, Sun GS, et al. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol 2013; 70:569-575.
16. Bielory B, Bielory L. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am 2010; 30:323-336.
17. Calonge M, Herreras JM. Clinical grading of atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol 2007; 7:442-445.
18. Guglielmetti S, Dart JK, Calder V. Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol 2010; 10:478-485.
19. Power WJ, Tugal-Tutkun I, Foster CS. Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology 1998; 105:637-642.
20. Bielory L, Frohman LP. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 1992; 89:1-15.
21. La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 2013; 39:18.
22. Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol 2008; 153 (Suppl. 1):17-21.
23. Tanaka M, Dogru M, Takano Y, et al. The relation of conjunctival and corneal findings in severe ocular allergies. Cornea 2004; 23:464-467.
24. Groneberg DA, Bielory L, Fischer A, et al. Animal models of allergic and inflammatory conjunctivitis. Allergy 2003; 58:1101-1113.
25. Schlereth S, Lee HS, Khandelwal P, et al. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis. Am J Pathol 2012; 180:2351-2360.
26. + mouse dendritic cells under normal conditions and in allergic immune responses. PLoS One 2013; 8:e64193.
27. Saban DR. The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation. Ocul Surf 2014; 12:87-99.
28. Saban DR, Calder V, Kuo CH, et al. New twists to an old story: novel concepts in the pathogenesis of allergic eye disease. Curr Eye Res 2013; 38:317-330.
29. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010; 28:445-489.
30. Le Gros G, Ben-Sasson SZ, Seder R, et al. Generation of interleukin 4 (IL-4)- producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172:921-929.
31. Swain SL, Weinberg AD, English M, et al. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-3806.
32. Kurata H, Lee HJ, O'Garra A, et al. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999; 11:677-688.
33. Zhu J, Guo L, Watson CJ, et al. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 2001; 166:7276-7281.
34. Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA 2004; 101:1993-1998.
35. Turner JD, Faulkner H, Kamgno J, et al. Th2 cytokines are associated with reduced worm burdens in a human intestinal Helminth infection. J Infect Dis 2003; 188:1768-1775.
36. Urban JF Jr, Noben-Trauth N, Donaldson DD, et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998; 8:255-264.
37. Lighvani AA, Frucht DM, Jankovic D, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA 2001; 98:15137-15142.
38. + T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol 1993; 5:1119-1128.
39. Mullen AC, High FA, Hutchins AS, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001; 292:1907-1910.
40. Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295:338-342.
41. Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002; 110:493-497.
42. Doodes PD, Cao Y, Hamel KM, et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008; 181:329-337.
43. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008; 205:799-810.
44. Kao CY, Huang F, Chen Y, et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 2005; 175:6676-6685.
45. Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003; 278:17036-17043.
46. Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177:566-573.
47. Yang XO, Chang SH, Park H, et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008; 205:1063-1075.
48. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-898.
49. Kurschus FC, Croxford AL, Heinen AP, et al. Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 2010; 40:3336-3346.
50. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496:513-517.
51. Malek TR, Yu A, Vincek V, et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167-178.
52. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3:253-257.
53. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18-32.
54. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-616.
55. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
56. + T cells to effector interleukin-4-producing T helper cells. Immunol Res 1995; 14:176-188.
57. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 2008; 105:10113-10118.
58. Magone MT, Whitcup SM, Fukushima A, et al. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J Allergy Clin Immunol 2000; 105:299-308.
59. Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia - the key to asthma? Immunol Rev 2001; 179:182-191.
60. Akbari O, Stock P, DeKruyff RH, et al. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003; 15:627-633.
61. Bonini S, Coassin M, Aronni S, et al. Vernal keratoconjunctivitis. Eye (Lond) 2004; 18:345-351.
62. Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 2007; 7:429-435.
63. Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin 2003; 43:41-58.
64. Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999; 29:1214-1222.
65. Metz DP, Hingorani M, Calder VL, et al. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100:817-824.
66. Uchio E, Ono SY, Ikezawa Z, et al. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000; 30:103-109.
67. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010; 11:289-293.
68. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6:507-514.
69. Taylor BC, Zaph C, Troy AE, et al. TSLP regulates intestinal immunity and inflammation in mouse models of Helminth infection and colitis. J Exp Med 2009; 206:655-667.
70. Merad M, Sathe P, Helft J, et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31:563-604.
71. Kitajima M, Ziegler SF. Cutting edge: identification of the thymic stromal lymphopoietin-responsive dendritic cell subset critical for initiation of type 2 contact hypersensitivity. J Immunol 2013; 191:4903-4907.
72. Mesnil C, Sabatel CM, Marichal T, et al. Resident CD11b(+)Ly6C(-) lung dendritic cells are responsible for allergic airway sensitization to house dust mite in mice. PLoS One 2012; 7:e53242.
73. Plantinga M, Guilliams M, Vanheerswynghels M, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013; 38:322-335.
74. Raymond M, Rubio M, Fortin G, et al. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. J Allergy Clin Immunol 2009; 124:1333-1342; e1331.
75. Yokota-Nakatsuma A, Takeuchi H, Ohoka Y, et al. Retinoic acid prevents mesenteric lymph node dendritic cells from inducing IL-13-producing inflammatory Th2 cells. Mucosal Immunol 2013; 7:786-801.
76. Gao Y, Nish SA, Jiang R, et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013; 39:722-732.
77. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol 1986; 136:949-954.
78. Stern ME, Siemasko K, Gao J, et al. Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005; 46:3239-3246.
79. Pelikan Z. Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa. Mol Vis 2013; 19:1453-1470.
80. Leonardi A, Borghesan F, Faggian D, et al. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129:151-158.
81. Fukushima A, Sumi T, Ishida W, et al. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis. Int Arch Allergy Immunol 2008; 147:206-212.
82. Zicari AM, Nebbioso M, Zicari A, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci 2013; 17:1242-1244.
83. Martin B, Hirota K, Cua DJ, et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31:321-330.
84. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10:479-489.
85. Pelletier M, Maggi L, Micheletti A, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115:335-343.
86. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-467.
87. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
88. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255-281.
89. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160:1532-1539.
90. Louis R, Lau LC, Bron AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161:9-16.
91. Mizutani N, Nabe T, Yoshino S. IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice. J Immunol 2014; 192:1372-1384.
92. McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181:4089-4097.
93. Zhao Y, Yang J, Gao YD, et al. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010; 151:297-307.
94. + regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol 2013; 162:16-24.
95. + T cells in nonstimulated allergic rhinitis patients sensitized to house dust mites. J Asthma 2012; 49:569-574.
96. + regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007; 148:53-63.
97. Cottrez F, Hurst SD, Coffman RL, et al. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000; 165:4848-4853.
98. Zuany-Amorim C, Haile S, Leduc D, et al. Interleukin-10 inhibits antigeninduced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95:2644-2651.
99. + regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29:771-781.
100. + T cells in the development of experimental murine allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 2007; 245:705-714.
101. + T cells suppress the development of murine allergic conjunctivitis. Int Arch Allergy Immunol 2007; 143:276-281.
102. Sakai K, Yokoyama A, Kohno N, et al. Effect of different sensitizing doses of antigen in a murine model of atopic asthma. Clin Exp Immunol 1999; 118:9-15.
103. Barwig C, Raker V, Montermann E, et al. Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(-)CD8(-) doublenegative T cells. Clin Exp Allergy 2010; 40:891-901.
104. Lee HS, Schlereth S, Khandelwal P, et al. Ocular allergy modulation to hi-dose antigen sensitization is a Treg-dependent process. PLoS One 2013; 8:e75769.
105. + circulating helper T cells is associated with active perennial allergic conjunctivitis. Clin Dev Immunol 2013; 2013:919742.
106. Grindebacke H, Wing K, Andersson AC, et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34:1364-1372.
107. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363:608-615.
108. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014; 133:621-631.
109. + cells in the nasal mucosa. J Allergy Clin Immunol 121:1467-1472; e1461.
110. Liu LL, Guo DD, Liang QX, et al. Sublingual immunotherapy for experimental allergic conjunctivitis in a murine model induced by Dermatophagoides farinae allergen. Int Arch Allergy Immunol 2013; 161:205-212.
111. Tian M, Wang Y, Lu Y, et al. Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4(+) CD25(+) regulatory T cells in peripheral blood of children with allergic asthma. Int Forum Allergy Rhinol 2014; 4:371-375.
112. Briseno CG, Murphy TL, Murphy KM. Complementary diversification of dendritic cells and innate lymphoid cells. Curr Opin Immunol 2014; 29C:69-78.
113. Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463:540-544.
114. Halim TY, Krauss RH, Sun AC, et al. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36:451-463.
115. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-1370.
116. Fukushima A, Sumi T, Fukuda K, et al. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide. Immunol Lett 2006; 107:32-40.
117. Reyes NJ, Mayhew E, Chen PW, et al. NKT cells are necessary for maximal expression of allergic conjunctivitis. Int Immunol 2010; 22:627-636.
118. Reyes NJ, Mayhew E, Chen PW, et al. Gammadelta T cells are required for maximal expression of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2011; 52:2211-2216.
119. Fukushima A, Fukata K, Ozaki A, et al. Exertion of the suppressive effects of IFN-gamma on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol 2002; 86:1166-1171.